Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acetylcholine receptor antibody
acoustic nerve
advances in neurology
adverse drug reaction
afebrile
agitation
anti GQ1b IgG antibody
antiviral agents
aphasia
areflexia
arteritides
arteritis, temporal
arteritis, temporal, recurrent
arthralgia
ataxia, sensory
atezolizumab
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
B cell lymphoma
brain biopsy
Broca's aphasia
burning paresthesia
cancer associated myopathy
carcinoma
carcinoma of lung
cardiotoxicity
CAT scan, emission, abnormal
cauda equina
cauda equina, enhancement
cauda equina, lesion of
CD19-directed chimeric antigen receptor T-cell therapy
cerebellitis
cerebellitis, autoimmune
cerebral arteries
cerebrovascular accident
chemotherapy, CNS treatment and complications with
chorea
coinfection
complications
confusion
confusional state, acute
cranial nerve palsies
cranial neuropathy
cranial neuropathy, multiple
creatine phosphokinase(CPK)elevated
cytokine release syndrome
dabrafenib
demyelinating disease
dentate nuclei
dentate nuclei, lesion of
diabetes insipidus
differential diagnosis
diplopia
disorientation
dropped head syndrome
drug abuse
drug induced neurologic disorders
duvalumab
dyspnea
efficacy
electroencephalogram, abnormalities of
electromyogram
encephalitis
encephalitis, autoimmune
encephalitis, viral
encephalopathy
encephalopathy, acute
episodic disorders
extralimbic encephalitis
face, numbness of
facial nerve palsy
fever
Fisher's syndrome
gammaglobulin therapy, intravenous
ganglionitis
glutamic acid decarboxylase, antibody
granulomatous hypophysitis
Guillain Barre syndrome
hallucination
hallucination, auditory
hallucination, visual
headache
hemiparesis
hemiplegia, progressive
hippocampal atrophy
hippocampus, hyperintense
Hodgkin's disease
human herpesvirus 6
hyperactivity
hypercalcemia
iatrogenic neurologic disorders
idiopathic
immune checkpoint inhibitors
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunologic disease
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
incidence
internal carotid artery
ipilimumab
JC virus
leukopenia
levamisole
limb-girdle weakness
limbic encephalitis
limbic system
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma, systemic
melanoma, malignant
memory, impairment of
meningismus
meningitis
meningitis, drug induced
meningoencephalitis
mental status, abnormal
mesial temporal lobe
middle cerebral artery
misdiagnosis
monoclonal antibodies
mortality
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, diffusion weighted
MRI, FLAIR
MRI, optic nerve
multiple organ failure
multiple sclerosis
muscle biopsy
muscle pain
muscle weakness
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myocarditis
myopathy
myopathy, inflammatory
myopathy, necrotizing
myopathy, necrotizing, immune-mediated
myositis
nausea and vomiting
neck weakness
neoplasm, metastatic
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS-treatment of
neurologic complications of, systemic cancer
neurologic complications of, systemic disease
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neuromuscular junction
neuromuscular junction, abnormality of
neuronopathy, sensory
neuroophthalmology
neuropathy
neuropathy, iatrogenic
neuropathy, medication induced
neuropathy, sensory
neurotoxic
nivolumab
ocular motility, disorders of
ophthalmoplegia
opportunistic infection
opportunistic infection, CNS
optic disc edema
optic nerve, enhancement
optic neuritis
optic neuropathy
orthostatic hypotension
paraneoplastic ganglionopathy
paresthesias
pembrolizumab
pituitary stalk
pituitary stalk, enlarged
plasmapheresis
pleocytosis of cerebrospinal fluid
polymerase chain reaction, false negative
polyneuropathy, chronic inflammatory demyelinating
precipitating factors
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
pruritus
pseudoathetosis
ptosis
ptosis, bilateral
radiation therapy, CNS treatment and complications with
rechallenge
recurrent
remote effect of cancer on the nervous system
respiratory failure
review article
rhabdomyolysis
risk factors
Romberg's sign
safety
sarcoidosis
sarcoidosis, CNS
seizure
sensory ganglia
sensory ganglia, abnormal
sensory loss
sensory loss, truncal
seronegative
Sjogren's syndrome
speech disorder
speech, slowed
steroid
steroid therapy, CNS treatment and complications with
systemic illness
temporal lobe, lesion
temporal lobe, lesion, bilateral
trametinib
treatment of neurologic disorder
tumor necrosis factor inhibitor
vasculitides
viral infection, CNS
visual acuity, decreased
visual loss
weakness
weakness, fatiguable
white matter disease
word-finding difficulty
workup
Showing articles 300 to 350 of 2043 << Previous Next >>

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Clinical Effectiveness of Direct Oral Anticoagulations vs Warfarin in Older Patients with Atrial Fibrillation and Ischemic Stroke
JAMA Neurol 76:1192-1202, Xian, Y.,et al, 2019

Diagnosis and Management of Dementia
JAMA 322:1589-1599, Arvanitakis, Z.,et al, 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Clinical Manifestations and Diagnosis of Nocardiosis
UptoDate May, Spelman, D., 2019

Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018

Subacute Progressive Ptosis, Ophthalmoplegia, Gait Instability, and Cognitive Changes
JAMA Neurol 75:1284-1285, Lin, J.,et al, 2018

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy
JAMA 320:1485-1486, Sholzberg, M. & Xu, Y., 2018

Atypical Presentation and Aggresive Evolution of Primary CNS Lymphoma (PCNSL)
Cancer Res Front 4:131-143, Topiwala, K.,et al, 2018

Andexxa-An Antidote for Apixaban and Rivaroxaban
JAMA 320:399-400, , 2018

Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018

Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018

Improved Stroke Prevention in Atrial Fibrillation after the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 49:2122-2128, Forslund, T.,et al, 2018

Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018

A 23-year-old woman with fever and vertical diplopia
Neurol 90:e2006-e2010, Lin, D.J.,et al, 2018

Encephalitis with mGluR5 antibodies
Neurol 90:e1964-e1972, Spatola, M.,et al, 2018

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NEJM 378:2191-2201, Hart, R.G.,et al, 2018

Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018

Treatable Bilateral Striatal Lesions Related to Anti-Dopamine 2 Receptor
Neurol 91:98-101, Marques-Matos, C.,et al, 2018

Acute Onset of Diplopia in Pregnancy
Neurol 91:e180-e184, Munro, Z. & Fernandez, D., 2018

Glutamate Receptor D2 Serum Antibodies in Pediatric Opsoclonus Myoclonus Ataxia Syndrome
Neurol 91:e714-e723, Berridge, G.,et al, 2018

Clnicopathologic Conference Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis
NEJM 379:870-878, CASE 27-2018, 2018

A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

Preventive Migraine Drug Approved
JAMA 320:1746, , 2018

A 35-year-old Woman with Diplopia, Ataxia, and Altered Mental Status
Neurol 91:e1942-e1946, Bauer, Z.,et al, 2018

Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018

Clinicopathologic Conference, Susacs Syndrome
NEJM 379:2152-2159, Case 37-2018, 2018

Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018

Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018

Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018

Persistent Postural-Perceptual Dizziness (PPPD): A Common, Characteristic and Treatable Cause of Chronic Dizziness
Pract Neurol 18:5-13, Popkirov, S.,et al, 2018

Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018

A 52-year-old woman with a 3 weeks of progressive gait ataxia and dysarthria
Neurol 90:e985-e989, Ly, C.,et al, 2018

Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018

A 75-year-old man with parkinsonism, mood depression, and weight loss
Neurol 90:572-575, Frattini, E.,et al, 2018

A 56-year-old woman with acute vertigo and diplopia
Neurol 90:748-752, Sharma, R.,et al, 2018

A 30-year-old man with headache and sleep disturbance
Neurol 90:e1535-e1540, English, S.W.,et al, 2018

Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018

Management of Bleeding in Patients Taking Oral Anticoagulants
JAMA 319:2032-2033, Anderson, I.,et al, 2018

Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome
AJNR 39:824-829, Zhang, T.,et al, 2018

Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants with Serotonin Syndrome
JAMA Neurol 75:566-572, Orlova, Y.,et al, 2018

Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018

Recurrent Dysarthria and Ataxia in a Young Girl
JAMA Neurol 75:125-126, Romba, M.,et al, 2018

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
JAMA Neurol 75:65-71, Hamid, S.H.M.,et al, 2018

Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation
Psychiatry.com 2018, Papp, A. & Onton, J.A., 2018

Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
AJNR 38:1070-1078, Kelley, B.P.,et al, 2017

Hashimotos Thyroiditis and Autoimmune Gastritis
Front Endocrinol 8:00092, Cellini,Miriam,et al, 2017

Central Nervous System Brucellosis Granuloma and White Matter Disease in Immunocompromised Patient
Emerg Infect Dis 23:978-981, Alqwaifly,M.,et al, 2017



Showing articles 300 to 350 of 2043 << Previous Next >>